Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms by Site × selinexor × Clear all

Sponsor

Conditions

Multiple Myeloma 7 Recurrence 5 Glioblastoma 4 Leukemia, Myeloid, Acute 3 Colorectal Neoplasms 3 Neoplasms, Plasma Cell 2 Melanoma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Glioma 2 Carcinoma, Squamous Cell 2 Brain Neoplasms 2 Astrocytoma 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Thymoma 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Richter's Transformation 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma 1

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 4 pembrolizumab 3 napabucasin 3 Paclitaxel 3 Irinotecan 3 pralsetinib 2 patritumab 2 Standard of Care 2 Pemetrexed 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 Ascorbic Acid 2 Albumin-Bound Paclitaxel 2 valrubicin 1 sotorasib 1 selpercatinib 1 ribociclib 1 relatlimab 1 pamiparib 1 osimertinib 1 ipatasertib 1 durvalumab 1 dostarlimab 1 cobimetinib 1 atezolizumab 1 alectinib 1 Tyrosine Kinase Inhibitors 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡